Forskning ved Københavns Universitet - Københavns Universitet

Forside

Hypertension--er det lige meget, hvordan vi saenker blodtrykket?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Hypertension--er det lige meget, hvordan vi saenker blodtrykket? / Mehlsen, Jesper.

I: Ugeskrift for Laeger, Bind 170, Nr. 36, 01.09.2008, s. 2782-4.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Mehlsen, J 2008, 'Hypertension--er det lige meget, hvordan vi saenker blodtrykket?', Ugeskrift for Laeger, bind 170, nr. 36, s. 2782-4.

APA

Mehlsen, J. (2008). Hypertension--er det lige meget, hvordan vi saenker blodtrykket? Ugeskrift for Laeger, 170(36), 2782-4.

Vancouver

Mehlsen J. Hypertension--er det lige meget, hvordan vi saenker blodtrykket? Ugeskrift for Laeger. 2008 sep 1;170(36):2782-4.

Author

Mehlsen, Jesper. / Hypertension--er det lige meget, hvordan vi saenker blodtrykket?. I: Ugeskrift for Laeger. 2008 ; Bind 170, Nr. 36. s. 2782-4.

Bibtex

@article{1332c5e97d59488f95f12abaebc6147a,
title = "Hypertension--er det lige meget, hvordan vi saenker blodtrykket?",
abstract = "ASCOT compared the effect of atenolol combined with a thiazide versus amlodipine with perindopril in hypertensive patients. It also studied the effect of atorvastatin in those with normal cholesterol. ASCOT concluded that reductions in cardiovascular events with atorvastatin were significant, and that amlodipine-based treatment prevented more cardiovascular events. The latter seemed to be due to better control of central blood pressure. Both statin and amlodipine-based treatments were cost-effective. According to the ASCOT study, it does matter how blood pressure is lowered.",
author = "Jesper Mehlsen",
year = "2008",
month = "9",
day = "1",
language = "Dansk",
volume = "170",
pages = "2782--4",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "36",

}

RIS

TY - JOUR

T1 - Hypertension--er det lige meget, hvordan vi saenker blodtrykket?

AU - Mehlsen, Jesper

PY - 2008/9/1

Y1 - 2008/9/1

N2 - ASCOT compared the effect of atenolol combined with a thiazide versus amlodipine with perindopril in hypertensive patients. It also studied the effect of atorvastatin in those with normal cholesterol. ASCOT concluded that reductions in cardiovascular events with atorvastatin were significant, and that amlodipine-based treatment prevented more cardiovascular events. The latter seemed to be due to better control of central blood pressure. Both statin and amlodipine-based treatments were cost-effective. According to the ASCOT study, it does matter how blood pressure is lowered.

AB - ASCOT compared the effect of atenolol combined with a thiazide versus amlodipine with perindopril in hypertensive patients. It also studied the effect of atorvastatin in those with normal cholesterol. ASCOT concluded that reductions in cardiovascular events with atorvastatin were significant, and that amlodipine-based treatment prevented more cardiovascular events. The latter seemed to be due to better control of central blood pressure. Both statin and amlodipine-based treatments were cost-effective. According to the ASCOT study, it does matter how blood pressure is lowered.

M3 - Tidsskriftartikel

VL - 170

SP - 2782

EP - 2784

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 36

ER -

ID: 34079591